Announcements Trials
Browse Landscape

Status

Completed 24Unknown 6Recruiting 6Not yet recruiting 3Terminated 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 51Observational 3

Sponsor

Cancer Type

Breast 2Genitourinary 1

Conditions

Breast Neoplasms 2Prostatic Neoplasms 1

Interventions

Observation 23Blood Specimen Collection 20Drug Therapy 14Surveys and Questionnaires 10Surgical Procedures, Operative 8Immune Checkpoint Inhibitors 8Immunotherapy 7Positron Emission Tomography Computed Tomography 5Hematologic Tests 5Watchful Waiting 4Neoadjuvant Therapy 4Fluorodeoxyglucose F18 4Bevacizumab 4tislelizumab 3envafolimab 3darolutamide 3Tyrosine Kinase Inhibitors 3Therapeutics 3Standard of Care 3Radiotherapy 3Letrozole 3Indocyanine Green 3Imatinib Mesylate 3Endosonography 3Endoscopic Mucosal Resection 3Docetaxel 3Cyclophosphamide 3Capecitabine 3Artificial Intelligence 3pertuzumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Observational × Docetaxel × Clear all
NCT06684054 2024-11-12

STFREiYTNBC

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Not yet recruiting
30 enrolled
Breast

Breast Neoplasms

NCT06430411 2024-05-28

OLIGOMET

Medical University of Vienna

Not yet recruiting
500 enrolled
Genitourinary

Prostatic Neoplasms

NCT05131893 2021-11-23

Neoadjuvant Treatment of Breast Cancer

National Institute of Oncology, Hungary

Not yet recruiting
300 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡